Keywords: sanofi-synthelabo, 1st-half, sales, up, france, generated, consolidated
Sanofi-Synthelabo 1st-half sales up 14.8%
Article | 29 July 2002
France's Sanofi-Synthelabo generated consolidated sales of 3.68 billioneuros ($3.71 billion) in the first half of 2002, an increase of 14.8% on a comparable basis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
